RAMACHANDARAM, Anantharaju et al. REAL-WORLD EVIDENCE FOR THE USE OF SGLT2 INHIBITORS IN PATIENTS WITH TYPE 2 DIABETES AT A MALAYSIAN TERTIARY CARE CENTRE. Journal of the ASEAN Federation of Endocrine Societies, [S. l.], v. 38, n. S3, p. 52, 2023. DOI: 10.15605/jafes.038.AFES.74. Disponível em: https://www.asean-endocrinejournal.org/index.php/JAFES/article/view/3325. Acesso em: 26 apr. 2026.